New England Research & Management, Inc. / AMGN
New England Research & Management, Inc.’s Amgen Inc Position
Does New England Research & Management, Inc. own Amgen Inc (AMGN)? Yes — 11.9K shares worth $4M (+1.67% of its 13F portfolio) as of Q2 2026, up from 9.8K shares the prior filed quarter.
Position Value
$4M
Q2 2026
Shares
11.9K
% of Portfolio
+1.67%
Quarters Held
25
currently held
Position History AMGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 11.9K | $4M | +1.67% |
| Q1 2026 | 9.8K | $3M | +1.46% |
| Q4 2025 | 6.5K | $2M | +0.93% |
| Q3 2025 | 5.0K | $1M | +0.64% |
| Q2 2025 | 4.6K | $1,290 | +0.61% |
| Q1 2025 | 2.5K | $792 | +0.40% |
| Q4 2024 | 5.5K | $1,425 | +0.73% |
| Q3 2024 | 10.6K | $3,407 | +1.60% |
| Q2 2024 | 8.1K | $2,520 | +1.21% |
| Q1 2024 | 9.0K | $2,546 | +1.25% |
| Q4 2023 | 5.8K | $1,671 | +0.89% |
| Q3 2023 | 10.0K | $2,677 | +1.53% |
| Q2 2023 | 14.2K | $3,159 | +1.83% |
| Q1 2023 | 10.1K | $2,431 | +1.43% |
| Q4 2022 | 5.3K | $1,387 | +0.80% |
| Q1 2022 | 2.7K | $643,000 | +0.33% |
| Q4 2021 | 2.8K | $621,000 | +0.30% |
| Q3 2021 | 3.1K | $658,000 | +0.34% |
| Q2 2021 | 6.7K | $2M | +0.84% |
| Q3 2020 | 1.4K | $356,000 | +0.26% |
| Q2 2020 | 3.7K | $880,000 | +0.63% |
| Q4 2019 | 954 | $230,000 | +0.15% |
| Q2 2019 | 9.8K | $2M | +1.22% |
| Q1 2019 | 9.6K | $2M | +1.23% |
| Q4 2018 | 8.2K | $2M | +1.25% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See New England Research & Management, Inc.’s full portfolio or all institutional holders of AMGN.